These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31779041)

  • 1. Neurokinin-1 and cytokine receptors as targets for therapy of chronic prurigo.
    Wallengren J
    J Eur Acad Dermatol Venereol; 2019 Dec; 33(12):2221-2222. PubMed ID: 31779041
    [No Abstract]   [Full Text] [Related]  

  • 2. Chronic Prurigo of Nodular Type: A Review.
    Zeidler C; Tsianakas A; Pereira M; Ständer H; Yosipovitch G; Ständer S
    Acta Derm Venereol; 2018 Feb; 98(2):173-179. PubMed ID: 29135018
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subacute and chronic prurigo effectively treated with recombination interferon-gamma: implications for participation of Th2 cells in the pathogenesis of prurigo.
    Tokura Y; Yagi H; Hanaoka K; Ito T; Towyama K; Sachi Y; Tanaka M; Sakamoto T; Sekizuka T; Furukawa F; Takigawa M
    Acta Derm Venereol; 1997 May; 77(3):231-4. PubMed ID: 9188879
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prurigo nodularis: an update on etiopathogenesis and therapy.
    Fostini AC; Girolomoni G; Tessari G
    J Dermatolog Treat; 2013 Dec; 24(6):458-62. PubMed ID: 23767411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Actinic prurigo].
    Neumann NJ; Hölzle E; Lehmann P;
    J Dtsch Dermatol Ges; 2004 May; 2(5):373-5. PubMed ID: 16281529
    [No Abstract]   [Full Text] [Related]  

  • 6. Prurigo nodularis: a review.
    Lee MR; Shumack S
    Australas J Dermatol; 2005 Nov; 46(4):211-18; quiz 219-20. PubMed ID: 16197418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prurigo Nodularis and Its Management.
    Zeidler C; Yosipovitch G; Ständer S
    Dermatol Clin; 2018 Jul; 36(3):189-197. PubMed ID: 29929592
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dupilumab in Treatment of Chronic Prurigo: A Case Series and Literature Review.
    Almustafa ZZ; Weller K; Autenrieth J; Maurer M; Metz M
    Acta Derm Venereol; 2019 Sep; 99(10):905-906. PubMed ID: 31233177
    [No Abstract]   [Full Text] [Related]  

  • 9. The NK1 receptor antagonist serlopitant for treatment of chronic pruritus.
    Ständer S; Spellman MC; Kwon P; Yosipovitch G
    Expert Opin Investig Drugs; 2019 Aug; 28(8):659-666. PubMed ID: 31272246
    [No Abstract]   [Full Text] [Related]  

  • 10. Role of Substance P and Its Receptor Neurokinin 1 in Chronic Prurigo: A Randomized, Proof-of-Concept, Controlled Trial with Topical Aprepitant.
    Ohanyan T; Schoepke N; Eirefelt S; Hoey G; Koopmann W; Hawro T; Maurer M; Metz M
    Acta Derm Venereol; 2018 Jan; 98(1):26-31. PubMed ID: 28853492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Olanzapine therapy for subacute prurigo.
    Hyun J; Gambichler T; Bader A; Altmeyer P; Kreuter A
    Clin Exp Dermatol; 2006 May; 31(3):464-5. PubMed ID: 16681609
    [No Abstract]   [Full Text] [Related]  

  • 12. Thalidomide and its dermatologic uses.
    Paghdal KV; Schwartz R
    Acta Dermatovenerol Croat; 2007; 15(1):39-44. PubMed ID: 17433179
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review of evidence-based treatments for prurigo nodularis.
    Qureshi AA; Abate LE; Yosipovitch G; Friedman AJ
    J Am Acad Dermatol; 2019 Mar; 80(3):756-764. PubMed ID: 30261199
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe resistant subacute prurigo successfully controlled by long-term cyclosporin.
    Daudén E; García-Díez A
    J Dermatolog Treat; 2003 Jan; 14(1):48-50. PubMed ID: 12745856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Keratoacanthomas arising in association with prurigo nodules in pruritic, actinically damaged skin.
    Wu TP; Miller K; Cohen DE; Stein JA
    J Am Acad Dermatol; 2013 Sep; 69(3):426-30. PubMed ID: 23664628
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thalidomide once more in the spotlight].
    Bronner GM; Koks CH; Beijnen JH
    Ned Tijdschr Geneeskd; 1999 Jan; 143(2):122. PubMed ID: 10086119
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of AIDS-associated prurigo nodularis with thalidomide.
    Herranz P; Pizarro A; De Lucas R; Arribas JR; García-Tobaruela A; Peña JM; Casado M
    Clin Exp Dermatol; 1998 Sep; 23(5):233-5. PubMed ID: 10233821
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of prurigo nodularis with thalidomide: a case report and review of the literature.
    Alfadley A; Al-Hawsawi K; Thestrup-Pedersen K; Al-Aboud K
    Int J Dermatol; 2003 May; 42(5):372-5. PubMed ID: 12755975
    [No Abstract]   [Full Text] [Related]  

  • 19. Efficacy of thalidomide in the treatment of prurigo nodularis.
    Taefehnorooz H; Truchetet F; Barbaud A; Schmutz JL; Bursztejn AC
    Acta Derm Venereol; 2011 May; 91(3):344-5. PubMed ID: 21279302
    [No Abstract]   [Full Text] [Related]  

  • 20. Teen with a diffuse erythematous, pruritic eruption.
    Worley CR; Buccolo LS; Boyd DA
    J Fam Pract; 2011 Jan; 60(1):37-9. PubMed ID: 21209978
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.